Gavish-Galilee Bio Applications Ltd.
Records under this name other than the patents Gavish-Galilee Bio Applications Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Back to Gavish-Galilee Bio Applications Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,188,741 | Targeting of Innate Immune Response to Tumor Site Formerly held In force · High confidence | In force | High confidence | |
| US 10,617,697 | Extracts of Edible Fungi Enriched in Vitamin D and Compostions Thereof and Their Use in the Treatment of Immune-Related Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,941,386 | Endoinulinases Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,639,345 | Methionine metabolic pathway inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,647,748 | Sulphonamides as methionine metabolic pathway inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,034,599 | System for treatment of polluted effluents Lapsed on the fee record Ended Jun 15, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 15, 2025 | USPTO record |
| US 10,821,179 | Proteins modified with (amino) monosaccharide-biotin adduct Lapsed on the fee record Ended Nov 3, 2024 · USPTO record | Lapsed on the fee record | Ended Nov 3, 2024 | USPTO record |
| US 9,358,307 | Targeting of Innate Immune Response to Tumor Site Formerly held Lapsed on the fee record Ended Jun 7, 2024 · High confidence | Lapsed on the fee record | Ended Jun 7, 2024 | High confidence |
| US 7,323,338 | Plants characterized by an increased content of methionine and related metabolites, methods of generating same and uses thereof Term ended Term ended Apr 13, 2023 · USPTO record | Term ended | Term ended Apr 13, 2023 | USPTO record |
| US 8,158,161 | Methods and pharmaceutical compositions useful for treating psoriasis Lapsed on the fee record Ended Apr 17, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 17, 2016 | USPTO record |